Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin for Voiding Dysfunction in Neurogenic Bladder
NCT01228370Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Apr 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of silodosin in neurogenic bladder, Voiding dysfunction, sponsored by JW Pharmaceutical Corporation. Started Apr 2011; status: completed.
02
Drugs
silodosin
03
Conditions
neurogenic bladderVoiding dysfunction
Beyond the preview
Go deeper on NCT01228370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228370.